chr21-33070340-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_138983.3(OLIG1):āc.94C>Gā(p.Leu32Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000129 in 1,546,894 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_138983.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OLIG1 | NM_138983.3 | c.94C>G | p.Leu32Val | missense_variant | 1/1 | ENST00000382348.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OLIG1 | ENST00000382348.2 | c.94C>G | p.Leu32Val | missense_variant | 1/1 | NM_138983.3 | P1 | ||
ENST00000454622.2 | n.201+564G>C | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.00000659 AC: 1AN: 151668Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000145 AC: 2AN: 138272Hom.: 0 AF XY: 0.0000267 AC XY: 2AN XY: 74938
GnomAD4 exome AF: 7.17e-7 AC: 1AN: 1395120Hom.: 0 Cov.: 32 AF XY: 0.00000145 AC XY: 1AN XY: 688062
GnomAD4 genome AF: 0.00000659 AC: 1AN: 151774Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74182
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 01, 2022 | The c.94C>G (p.L32V) alteration is located in exon 1 (coding exon 1) of the OLIG1 gene. This alteration results from a C to G substitution at nucleotide position 94, causing the leucine (L) at amino acid position 32 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at